COMMUNIQUÉS West-GlobeNewswire

GENFIT: Les données présentées au congrès EASL ILC 2018 souligneront les avancées de la Société en matière de diagnostic de la NASH, de combinaisons de traitement, d'analyse d'images via deep-learning
28/03/2018
GENFIT: Les données présentées au congrès EASL ILC 2018 souligneront les avancées de la Société en matière de diagnostic de la NASH, de combinaisons de traitement, d'analyse d'images via deep-learning Lille (France), [...]
Hydropothecary reports fiscal 2018 second quarter results; achieves revenue visibility and business certainty for the first year following cannabis legalization
28/03/2018
GATINEAU, Quebec, March 28, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSX VENTURE:THCX) (the "Company") reported its financial results for the three and six months ended January 31, 2018, the second [...]
Hydropothecary déclare les résultats du deuxième trimestre de l’exercice 2018, démontrant la prévisibilité de ses revenus et sa certitude commerciale dès la première année suivant la légalisation du cannabis
28/03/2018
GATINEAU, Quebec, 28 mars 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSX CROISSANCE:THCX) (la « Société ») a publié ses résultats financiers pour le trimestre et le semestre clos le 31 janvier 2018, à savoir le [...]
PotNetwork Holding Inc.’s Diamond CBD Releases Corporate Video Highlighting Consumer Response to its Natural Health and Wellness Products
28/03/2018
FT LAUDERDALE, Fla., March 28, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holding, Inc. (OTC Pink:POTN) On Wednesday, March 28th, 2018, PotNetwork Holding Inc.’s wholly owned subsidiary, Diamond CBD Inc. [...]
Assembly Biosciences Announces ABI-H0731 Phase 1b Interim Data Accepted as a Late-Breaker Poster at The International Liver Congress™ (EASL)
28/03/2018
INDIANAPOLIS and SAN FRANCISCO, March 28, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB ), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of [...]
Nexstim Plc: Resolutions of the annual general meeting of shareholders, 28 March 2018
28/03/2018
Company announcement, Helsinki, 28 March 2018, at 12 PM Nexstim Plc: Resolutions of the annual general meeting of shareholders, 28 March 2018 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted [...]
Enzymatica AB: Enzymatica - publication of the annual report 2017
28/03/2018
Press release Lund, 28 march 2018 Enzymatica - publication of the annual report 2017 Enzymatica announces today that the annual report 2017 is available on the company's web site www.enzymatica.se . The annual report is [...]
BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System
28/03/2018
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA) for its first [...]
Novartis to present predictability data for brolucizumab in nAMD from pivotal HAWK and HARRIER trials at ARVO
28/03/2018
Basel, March 28, 2018 - Novartis will present new data from the HAWK and HARRIER Phase III trials at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting, Honolulu, April 29 - May [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
28/03/2018
REGULATED INFORMATION GHENT, Belgium, 28 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Kiadis Pharma on track with European regulatory review for ATIR101
28/03/2018
Kiadis Pharma on track with European regulatory review for ATIR101 Responses submitted to EMA Day 120 list of questions Amsterdam, The Netherlands, March 28, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company [...]
Arcturus Therapeutics Initiates Lawsuit Against Joseph E. Payne to Protect the Interests of Arcturus Shareholders
28/03/2018
Complaint Details Extensive Misconduct by Mr. Payne during Tenure as CEO Cites Mr. Payne’s Self-Dealing and Inappropriate Business Conflicts of Interest SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Arcturus [...]
REVA Announces First Implant of the Fantom Encore Bioresorbable Scaffold in Switzerland
28/03/2018
SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced the first implant of the Fantom [...]
EDAP TMS SA : EDAP Reports 2017 Annual Results
27/03/2018
2017 Highlights 2017 revenue on par with 2016; lower HIFU capital equipment sales offset by double-digit HIFU treatment revenue growth CMS issued C-Code allocation for reimbursement of HIFU for prostate tissue ablation [...]
IntelGenx Announces Update on Private Placement and Proposed LaboVal Acquisition
27/03/2018
SAINT LAURENT, Quebec, March 27, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX ) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces that, due to market conditions, it will not be proceeding with [...]
Apricus Biosciences Announces Proposed Public Offering
27/03/2018
SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has commenced a [...]
Dyadic International Announces 2017 Year End Results and Recent Developments
27/03/2018
$49.1 million of cash, cash equivalents and investment securities as of December 31, 2017 Successfully executed two funded collaborations in 2017 and signed three new collaborations in 2018 Early data generated from our [...]
Amarin Commemorates National Triglycerides Day on March 28
27/03/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, March 27, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2017 Financial Results on April 3, 2018
27/03/2018
HOUSTON, March 27, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]

Pages